136 related articles for article (PubMed ID: 25752765)
1. Vaginal Lactobacillus gasseri CMUL57 can inhibit herpes simplex type 2 but not Coxsackievirus B4E2.
Kassaa IA; Hober D; Hamze M; Caloone D; Dewilde A; Chihib NE; Drider D
Arch Microbiol; 2015 Jun; 197(5):657-64. PubMed ID: 25752765
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of herpes simplex virus type 2 by vaginal lactobacilli.
Conti C; Malacrino C; Mastromarino P
J Physiol Pharmacol; 2009 Dec; 60 Suppl 6():19-26. PubMed ID: 20224147
[TBL] [Abstract][Full Text] [Related]
3. Antiviral effects of Lactobacillus crispatus against HSV-2 in mammalian cell lines.
Mousavi E; Makvandi M; Teimoori A; Ataei A; Ghafari S; Samarbaf-Zadeh A
J Chin Med Assoc; 2018 Mar; 81(3):262-267. PubMed ID: 29037754
[TBL] [Abstract][Full Text] [Related]
4. Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo.
Dai W; Wu Y; Bi J; Wang S; Li F; Kong W; Barbier J; Cintrat JC; Gao F; Gillet D; Su W; Jiang C
Viruses; 2018 Mar; 10(3):. PubMed ID: 29522484
[TBL] [Abstract][Full Text] [Related]
5. The application of a plasmid DNA encoding IFN-alpha 1 postinfection enhances cumulative survival of herpes simplex virus type 2 vaginally infected mice.
Härle P; Noisakran S; Carr DJ
J Immunol; 2001 Feb; 166(3):1803-12. PubMed ID: 11160227
[TBL] [Abstract][Full Text] [Related]
6. Antiviral Effect of Retro-2.1 against Herpes Simplex Virus Type 2 In Vitro.
Dai W; Wu Y; Bi J; Wang J; Wang S; Kong W; Barbier J; Cintrat JC; Gao F; Jiang Z; Gillet D; Su W; Jiang C
J Microbiol Biotechnol; 2018 Jun; 28(6):849-859. PubMed ID: 29847864
[TBL] [Abstract][Full Text] [Related]
7. The anti-HSV-2 effect of alumen: In vitro and in vivo experimental studies.
Hong L; Xu X; Chen L; Li B; Wu D; Hu M; Sun Q; Zhu X; Wu W; Hong S; Ding W; Min J; Xu Q
J Huazhong Univ Sci Technolog Med Sci; 2011 Dec; 31(6):828-833. PubMed ID: 22173507
[TBL] [Abstract][Full Text] [Related]
8. Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization.
Gallichan WS; Rosenthal KL
J Infect Dis; 1998 May; 177(5):1155-61. PubMed ID: 9592997
[TBL] [Abstract][Full Text] [Related]
9. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
[TBL] [Abstract][Full Text] [Related]
10. A VP26-mNeonGreen Capsid Fusion HSV-2 Mutant Reactivates from Viral Latency in the Guinea Pig Genital Model with Normal Kinetics.
Pieknik JR; Bertke AS; Tang S; Krause PR
Viruses; 2018 May; 10(5):. PubMed ID: 29738431
[TBL] [Abstract][Full Text] [Related]
11. Infectivity and growth kinetics of Herpes Simplex Virus type-2 in MOLT4 CCR5+ and CEM CCR5+ T cell lines.
Desai D; Bhutkar M; Kulkarni S
Microb Pathog; 2018 Oct; 123():82-88. PubMed ID: 29944889
[TBL] [Abstract][Full Text] [Related]
12. Herpes Simplex Virus Growth, Preparation, and Assay.
Sutter SO; Marconi P; Meier AF
Methods Mol Biol; 2020; 2060():57-72. PubMed ID: 31617172
[TBL] [Abstract][Full Text] [Related]
13. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
14. Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice.
Hayashi K; Hayashi T; Miyazawa K; Tomoda A
J Pharmacol Sci; 2010; 114(1):85-91. PubMed ID: 20736512
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antiviral activity of Lactobacillus acidophilus and Glycyrrhiza glabra against Herpes Simplex-1 Virus (HSV-1) and Vesicular Stomatitis Virus (VSV): experimental and In Silico insights.
Elebeedy D; Ghanem A; Aly SH; Ali MA; Faraag AHI; El-Ashrey MK; Salem AM; Hassab MAE; Maksoud AIAE
BMC Microbiol; 2023 Jun; 23(1):173. PubMed ID: 37391715
[TBL] [Abstract][Full Text] [Related]
16. Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections.
Whaley KJ; Zeitlin L; Barratt RA; Hoen TE; Cone RA
J Infect Dis; 1994 Mar; 169(3):647-9. PubMed ID: 8158042
[TBL] [Abstract][Full Text] [Related]
17. A short-term plaque assay for antiviral drug research on herpes simplex virus type 2.
Muratore O; Tonoli EL; Pesce Schito A
New Microbiol; 1996 Jul; 19(3):257-61. PubMed ID: 8841042
[TBL] [Abstract][Full Text] [Related]
18. Antiviral and virucidal activities against herpes simplex viruses of umesu phenolics extracted from Japanese apricot.
Nishide M; Ikeda K; Mimura H; Yoshida M; Mitani T; Hajime Koyama A
Microbiol Immunol; 2019 Sep; 63(9):359-366. PubMed ID: 31301156
[TBL] [Abstract][Full Text] [Related]
19. Herpes Simplex Virus Type 2 Infection-Induced Expression of CXCR3 Ligands Promotes CD4
Zhang M; Deng X; Guan X; Geng L; Fu M; Zhang B; Chen R; Hu H; Hu K; Zhang D; Li M; Liu Y; Gong S; Hu Q
Front Immunol; 2018; 9():2932. PubMed ID: 30619292
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization.
Thapa M; Kuziel WA; Carr DJ
J Virol; 2007 Apr; 81(8):3704-13. PubMed ID: 17267483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
